NGF and Alzheimer disease: Because AAV serotype 2 (AAV2)-NGF vectors represent a more convenient and less expensive method of gene delivery and resulted in long-term gene expression in non-human primate brains [64], Tuszynski et al. conducted a second phase 1 clinical trial on 10 patients with AD (Figure 2).